Showing results (91-100 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|May 13, 2017
Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosisJack Burks, Thomas S Marshall, Xiaolan Ye
Clinicoeconomics and Outcomes Research : CEOR|November 9, 2013
Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference valuesWilliam Dunlop, Itrat Iqbal, Ifty Khan, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 26, 2013
Challenges in measuring and valuing productivity costs, and their relevance in mood disordersBenedikte R Lensberg, Michael F Drummond, Natalya Danchenko, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 21, 2012
Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, CanadaJean-Eric Tarride, Mahbubul Haq, Valerie H Taylor, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 14, 2011
Cost-effectiveness analysis of initial HIV treatment under Italian guidelinesGiorgio L Colombo, Vincenzo Colangeli, Antonio Di Biagio, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studiesKem P Krueger, A Christie Nelson
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumabFrancesco Patti, Angelo Pappalardo
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectivenessFiras Badin, John Hayslip
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Pharmacoeconomic considerations in the treatment of breast cancerAthanasios Pallis, Vasiliki Tsiantou, Efi Simou, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational studyLinda Kemp, John Haughney, Neil Barnes, et al.
Pageof 102